| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 103,242 | 106,105 | 79,004 | 119,671 | | Cost of Revenue | 85,778 | 104,128 | 90,778 | 119,804 | | | Gross Profit | 17,464 | 1,977 | (11,774) | (133) | | | Operating Expenses | | Research Development | 4,716 | 5,723 | 7,454 | 8,883 | | Selling General and Administrative | 10,606 | 42,510 | (4,593) | 35,943 | | Non Recurring | (4,390) | (3,473) | 43,002 | 32,280 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,142 | (42,783) | (57,637) | (77,239) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,184 | 3,268 | 2,721 | 16,161 | | Earnings Before Interest And Taxes | 10,716 | (39,515) | (54,916) | (61,078) | | Interest Expense | 2,430 | 2,819 | 2,986 | 2,734 | | Income Before Tax | 8,286 | (42,334) | (57,902) | (63,812) | | Income Tax Expense | (55) | (215) | (204) | 265 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,955 | (42,119) | (57,698) | (64,077) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,341 | (42,119) | (57,698) | (64,077) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,341 | ($42,119) | ($57,698) | ($64,077) |
|
0.51% Nasdaq 
Income Statement
